Similar findings have been observed in rheumatoid arthritis, where subjects with destructive disease (that required joint replacement) had higher initial levels of 1-F21 aggrecan compared to subjects with non-destructive disease when evaluated up to 12 years later [47]. The gene discussed is ACAN; the disease is rheumatoid arthritis.